Loading chat...
IN SB0080
Bill
AI Summary
Senate Enrolled Act No. 80 - Summary
-
Board of pharmacy must adopt emergency rules by July 1, 2016 governing pharmacist professional determinations and "relationship on record" requirements for ephedrine and pseudoephedrine sales.
-
Board shall review pharmacist professional determinations and take disciplinary action against pharmacists who violate rules concerning these determinations for ephedrine and pseudoephedrine sales.
-
Board may declare products as extraction resistant or conversion resistant forms of ephedrine or pseudoephedrine if they do not pose significant risk of methamphetamine manufacturing, in consultation with state police.
-
Pharmacists who refuse in good faith to sell ephedrine or pseudoephedrine based on professional judgment are immune from civil liability unless refusal constitutes gross negligence or intentional misconduct.
-
Products determined to be extraction resistant or conversion resistant may be sold to purchasers without established pharmacy relationships, up to 720 milligrams per package with 30 milligrams per tablet maximum.
Legislative Description
Ephedrine and pseudoephedrine. Requires the Indiana board of pharmacy (board) to adopt emergency rules that are effective July 1, 2016, concerning: (1) professional determinations made; and (2) a relationship on record with the pharmacy; concerning the sale of ephedrine or pseudoephedrine. Requires the board to: (1) review professional determinations made; and (2) discipline a pharmacist who violates a rule concerning a professional determination made; concerning the sale of ephedrine or pseudoephedrine. Allows the board, in consultation with the state police, to declare a product to be an extraction resistant or a conversion resistant form of ephedrine or pseudoephedrine. Specifies that
Last Action
Public Law 4
3/21/2016